T3 Companies, LLC

Position in CGC — Canopy Growth Corp

CIK 2052441 NEW YORK, NY

Back to CGC Full portfolio

Position in CGC

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$0

+$0 QoQ

Shares Held

0

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Derivatives in CGC

reported options exposure · as of Mar 31, 2026

CallValue

$21,352

CallShares

22,500

PutValue

$0

PutShares

0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

T3 Companies, LLC holds $8,117,605 across 2 Drug Manufacturers - Specialty & Generic names.

#	Ticker	Company	Shares	Value (USD)	Open
1	LQDA	Liquidia Corp	205,750	$7,765,005
2	HROW	Harrow, Inc.	10,000	$352,600

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,352	22,500	-89.5%	Call	Sole	2026-05-07
2025-12-31	$243,618	213,700	—	Call	Sole	2026-02-11
No filing history on record for this holder in this stock.

T3 Companies, LLC

Position in CGC

Derivatives in CGC

Position in Drug Manufacturers - Specialty & Generic

All Filings in CGC